Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: J Immunother. 2012 Feb;35(2):159–168. doi: 10.1097/CJI.0b013e318247642f

Figure 2. Cellular immune response against CMV in CMV-seropositive GBM patients.

Figure 2

A. Precursor frequency of pp65- and IE1-specific T cells in the peripheral blood of CMV-seropositive GBM patients at diagnosis compared to 7 healthy CMV-seropositive controls. B. Heatmap summarizing the results of the tissue reactivity (IHC and ISH) as well as the corresponding pp65 and IE1 precursor frequency in the peripheral blood (PB) of our patient cohort. SD: standard deviation from the mean value for healthy donors.